Kolkata: The Covid experience is helping city doctors treat critical patients with respiratory distress. A woman in the 26th ...

Alice Bell, the ex-wife of “Today” show weathercaster and morning TV staple Al Roker, has died. She was 77. Bell’s death was ...

The global pediatric mask market share is expected to grow from USD 734.04 million in 2023 to USD 1,068.48 million by 2031, ...

When using high-flow nasal cannula (HFNC), setting a higher flow rate of 60 vs 40 L/min for post-extubation care did not improve key outcomes.

Oxygen is a gas. Getting a shot of it up your nose is a blast. In 1975 you would have thought I was talking about something ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

Now, the Food and Drug Administration (FDA) has expanded approval for Johnson & Johnson's nasal spray, Spravato, to be used as a standalone treatment for people with severe depression who haven't ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

He required help to go to the toilet and was on oxygen via a nasal cannula. North West Wales senior coroner Kate Robertson said Betsi Cadwaladr University Health Board and a health care support ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...